首页> 美国卫生研究院文献>Frontiers in Genetics >Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases
【2h】

Cartography of Pathway Signal Perturbations Identifies Distinct Molecular Pathomechanisms in Malignant and Chronic Lung Diseases

机译:通路信号扰动的制图确定了恶性和慢性肺疾病中不同的分子致病机理

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Lung diseases are described by a wide variety of developmental mechanisms and clinical manifestations. Accurate classification and diagnosis of lung diseases are the bases for development of effective treatments. While extensive studies are conducted toward characterization of various lung diseases at molecular level, no systematic approach has been developed so far. Here we have applied a methodology for pathway-centered mining of high throughput gene expression data to describe a wide range of lung diseases in the light of shared and specific pathway activity profiles. We have applied an algorithm combining a Pathway Signal Flow (PSF) algorithm for estimation of pathway activity deregulation states in lung diseases and malignancies, and a Self Organizing Maps algorithm for classification and clustering of the pathway activity profiles. The analysis results allowed clearly distinguish between cancer and non-cancer lung diseases. Lung cancers were characterized by pathways implicated in cell proliferation, metabolism, while non-malignant lung diseases were characterized by deregulations in pathways involved in immune/inflammatory response and fibrotic tissue remodeling. In contrast to lung malignancies, chronic lung diseases had relatively heterogeneous pathway deregulation profiles. We identified three groups of interstitial lung diseases and showed that the development of characteristic pathological processes, such as fibrosis, can be initiated by deregulations in different signaling pathways. In conclusion, this paper describes the pathobiology of lung diseases from systems viewpoint using pathway centered high-dimensional data mining approach. Our results contribute largely to current understanding of pathological events in lung cancers and non-malignant lung diseases. Moreover, this paper provides new insight into molecular mechanisms of a number of interstitial lung diseases that have been studied to a lesser extent.
机译:肺部疾病由多种发育机制和临床表现来描述。肺部疾病的准确分类和诊断是开发有效治疗方法的基础。尽管已进行了广泛的研究以分子水平表征各种肺部疾病,但迄今为止尚未开发出系统的方法。在这里,我们已经应用了一种以途径为中心的高通量基因表达数据挖掘方法,以根据共享的和特定的途径活性图来描述广泛的肺部疾病。我们已经应用了一种算法,该算法结合了用于评估肺部疾病和恶性肿瘤中通路活性失调状态的通路信号流(PSF)算法和用于通路活性谱的分类和聚类的自组织映射算法。分析结果可以清楚地区分癌症和非癌症肺部疾病。肺癌的特征在于与细胞增殖,代谢有关的途径,而非恶性肺部疾病的特征在于与免疫/炎症反应和纤维化组织重塑有关的途径的失调。与肺恶性肿瘤相反,慢性肺疾病具有相对异质的通路失调特征。我们确定了三组间质性肺疾病,并表明特征性病理过程(如纤维化)的发展可以通过不同信号通路的失调来引发。总之,本文使用以路径为中心的高维数据挖掘方法从系统角度描述了肺部疾病的病理学。我们的结果很大程度上有助于当前对肺癌和非恶性肺病病理事件的了解。此外,本文提供了对一些间质性肺疾病的分子机制的新见解,而这些间质性肺疾病的研究程度较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号